Doctors Note Logo

Published on: 9/24/2026

What are the common Vraylar side effects?

Common Vraylar (cariprazine) side effects include restlessness or an urge to move (akathisia), tremor, muscle stiffness, drowsiness or insomnia, nausea, vomiting, indigestion, constipation, increased appetite, weight gain, and anxiety, while less common but serious effects can involve uncontrollable movements (tardive dyskinesia), high blood sugar, high fever with confusion, fainting, or unusual mood changes. Many of these effects depend on your dose, how long you have been taking it, and what other medications or conditions you have, and because Vraylar stays in the body for weeks, reactions can appear or linger after a dose change, so review the full details below before assuming a symptom is harmless.

If you are unsure whether what you are feeling is an expected adjustment period or a warning sign that needs prompt medical attention, a free, instant, online symptom check can help you sort out the possibilities in just a few minutes. It asks the same kinds of questions a clinician would, then points you toward the level of care that fits your situation, which is especially useful when side effects overlap with the very symptoms you are treating. Bring those results to your prescriber so you can make an informed decision together instead of stopping or adjusting Vraylar on your own.

Last reviewed for medical accuracy: 09/24/2026

answer background

Explanation

Understanding Vraylar and Its Side Effects

Vraylar (cariprazine) is an antipsychotic medication commonly prescribed to treat conditions like schizophrenia and bipolar I disorder. While many people benefit from improved mood stability, reduced hallucinations, or fewer manic episodes, it’s important to know about potential Vraylar side effects. This guide covers what you might experience, how to manage common reactions, and when to seek medical help.


How Vraylar Works and Why Side Effects Occur

  • Vraylar balances certain brain chemicals (dopamine and serotonin) to help regulate mood and thought processes.
  • Any change in these chemicals can bring relief—but also unintended reactions.
  • Side effects vary by person, dosage, and how long you’ve been taking the medication.

Common Vraylar Side Effects

Most people on Vraylar experience mild to moderate side effects that often improve over time. If these effects persist or worsen, let your doctor know.

Very Common (affects more than 10% of people)

  • Tiredness or drowsiness
    You may feel sleepy, especially when you first start taking Vraylar or after a dose increase.
  • Extrapyramidal symptoms (EPS)
    These include shaky movements, tremors, restlessness, or muscle stiffness.
  • Nausea
    Mild stomach upset often settles after a few days.

Common (affects 1–10% of people)

  • Dizziness or lightheadedness
    Especially upon standing; get up slowly from sitting or lying down.
  • Headache
    Generally mild; over-the-counter pain relievers can help.
  • Dry mouth
    Sugary gum or frequent sips of water can ease this.
  • Weight gain
    A gradual increase in appetite is possible—maintaining a balanced diet and regular exercise can counteract this.
  • Insomnia or sleep disturbances
    You may have trouble falling or staying asleep.
  • Anxiety or restlessness
    Some people feel jittery or on edge.

Less Common but Notable Side Effects

These reactions are less frequent but worth watching:

  • Blurred vision
    Avoid driving until you know how Vraylar affects your eyesight.
  • Constipation
    High-fiber diet, plenty of water, and exercise can help.
  • Increased heart rate
    Report palpitations or a racing heart to your doctor.
  • Orthostatic hypotension
    A significant drop in blood pressure when standing, causing faintness.
  • Elevated cholesterol or blood sugar
    Regular lab tests can monitor these levels.

Serious Side Effects: When to Seek Help

While rare, some Vraylar side effects can be severe. If you experience any of these, seek medical attention immediately:

  • Signs of neuroleptic malignant syndrome (NMS)
    High fever, stiff muscles, confusion, sweating, and fast heart rate.
  • Severe involuntary movements (tardive dyskinesia)
    Lip smacking, tongue thrusting, or uncontrollable jerky movements.
  • Severe allergic reactions
    Rash, itching, swelling of face or throat, trouble breathing.
  • Uncontrollable shaking or muscle stiffness
    Especially if accompanied by fever.
  • Thoughts of self-harm or suicide
    Any new or worsening mental health symptoms.

Tips for Managing Vraylar Side Effects

  1. Start low, go slow
    Your doctor may begin with a low dose and gradually increase to minimize side effects.
  2. Stay hydrated and eat balanced meals
    Helps counter nausea, dry mouth, and constipation.
  3. Monitor your weight and vitals
    Regularly check weight, blood pressure, cholesterol, and blood sugar.
  4. Keep a side effect diary
    Note when each side effect occurs, its severity, and any patterns.
  5. Adjust daily routine
    • Take Vraylar at the same time each day.
    • Avoid driving if you feel dizzy or drowsy.
    • Rise slowly from sitting to prevent lightheadedness.

When You’re Unsure: Online Symptom Checker

If you’re experiencing new or worsening symptoms and want a quick assessment, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. This tool can help you decide whether to seek immediate care or discuss concerns with your provider.


Talking with Your Doctor

Always keep an open dialogue with your healthcare team. When discussing vraylar side effects, be prepared to share:

  • Which symptoms you’re experiencing
  • Their frequency and intensity
  • Any other medications or supplements you’re taking
  • Changes in mood, appetite, sleep, or energy

Your doctor might adjust your dose, switch medications, or recommend supportive therapies (like counseling, physical therapy for stiff muscles, or dietary changes).


Don’t Hesitate to Seek Emergency Care

Some reactions can be life threatening. If you notice:

  • Severe muscle rigidity with high fever
  • Trouble breathing or swallowing
  • Symptoms of a heart attack (chest pain, arm or jaw discomfort)
  • Thoughts of harming yourself

Call emergency services or go to the nearest ER immediately.


Key Takeaways

  • Vraylar side effects range from mild (drowsiness, nausea) to serious (NMS, tardive dyskinesia).
  • Most side effects improve over time or with dose adjustments.
  • Maintain regular check-ups and lab tests to monitor your health.
  • Keep a side effect diary to track symptoms and share with your doctor.
  • Use a free, online symptom check, using the doctor approved Ubie Symptom Checker if you need quick guidance.
  • Always speak to a doctor about anything that could be life threatening or serious.

Your health and safety come first. Never hesitate to reach out to your healthcare provider if you have concerns about vraylar side effects.

(References)

  • * Solmi M, Murru A, Pacchiarotti I, Undurraga J, Veronese N, Fornaro M, Stubbs B, Monaco F, Vieta E, Seeman MV, Correll CU, Carvalho AF. Safety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review. Ther Clin Risk Manag. 2017;13:757-777. doi: 10.2147/TCRM.S117321. Epub 2017 Jun 29. PMID: 28721057; PMCID: PMC5499790.

  • * Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Bond DJ, Frey BN, Sharma V, Goldstein BI, Rej S, Beaulieu S, Alda M, MacQueen G, Milev RV, Ravindran A, O'Donovan C, McIntosh D, Lam RW, Vazquez G, Kapczinski F, McIntyre RS, Kozicky J, Kanba S, Lafer B, Suppes T, Calabrese JR, Vieta E, Malhi G, Post RM, Berk M. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord. 2018 Mar;20(2):97-170. doi: 10.1111/bdi.12609. Epub 2018 Mar 14. PMID: 29536616; PMCID: PMC5947163.

  • * Pillinger T, McCutcheon RA, Vano L, Mizuno Y, Arumuham A, Hindley G, Beck K, Natesan S, Efthimiou O, Cipriani A, Howes OD. Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis. Lancet Psychiatry. 2020 Jan;7(1):64-77. doi: 10.1016/S2215-0366(19)30416-X. Epub 2019 Dec 17. PMID: 31860457; PMCID: PMC7029416.

  • * Wu H, Siafis S, Hamza T, Schneider-Thoma J, Davis JM, Salanti G, Leucht S. Antipsychotic-Induced Weight Gain: Dose-Response Meta-Analysis of Randomized Controlled Trials. Schizophr Bull. 2022 May 7;48(3):643-654. doi: 10.1093/schbul/sbac001. PMID: 35137229; PMCID: PMC9077426.

  • * Schneider-Thoma J, Chalkou K, Dörries C, Bighelli I, Ceraso A, Huhn M, Siafis S, Davis JM, Cipriani A, Furukawa TA, Salanti G, Leucht S. Comparative efficacy and tolerability of 32 oral and long-acting injectable antipsychotics for the maintenance treatment of adults with schizophrenia: a systematic review and network meta-analysis. Lancet. 2022 Feb 26;399(10327):824-836. doi: 10.1016/S0140-6736(21)01997-8. PMID: 35219395.

  • * Orzelska-Górka J, Mikulska J, Wiszniewska A, Biała G. New Atypical Antipsychotics in the Treatment of Schizophrenia and Depression. Int J Mol Sci. 2022 Sep 13;23(18). doi: 10.3390/ijms231810624. Epub 2022 Sep 13. PMID: 36142523; PMCID: PMC9500595.

  • * Siafis S, Wu H, Wang D, Burschinski A, Nomura N, Takeuchi H, Schneider-Thoma J, Davis JM, Leucht S. Antipsychotic dose, dopamine D2 receptor occupancy and extrapyramidal side-effects: a systematic review and dose-response meta-analysis. Mol Psychiatry. 2023 Aug;28(8):3267-3277. doi: 10.1038/s41380-023-02203-y. Epub 2023 Aug 3. PMID: 37537284; PMCID: PMC10618092.

  • * Yildiz A, Siafis S, Mavridis D, Vieta E, Leucht S. Comparative efficacy and tolerability of pharmacological interventions for acute bipolar depression in adults: a systematic review and network meta-analysis. Lancet Psychiatry. 2023 Sep;10(9):693-705. doi: 10.1016/S2215-0366(23)00199-2. PMID: 37595997.

  • * DeBattista C, Schatzberg AF. The Black Book of Psychotropic Dosing and Monitoring. Psychopharmacol Bull. 2024 Jul 8;54(3):8-59. doi: 10.64719/pb.4493. PMID: 38993656; PMCID: PMC11235576.

  • * Koziej S, Kowalczyk E, Soroka E. Cariprazine in Psychiatry: A Comprehensive Review of Efficacy, Safety, and Therapeutic Potential. Med Sci Monit. 2024 Sep 20;30:e945411. doi: 10.12659/MSM.945411. Epub 2024 Sep 20. PMID: 39300746; PMCID: PMC11421304.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.